Barricade Therapeutics Corp

Biotechnology · FORT WORTH, TX

BiotechnologySEC Form D

Barricade Therapeutics Corp filed a Form D with the U.S. Securities and Exchange Commission on June 10, 2026 for a private securities offering.

Incorporated in Delaware and based in FORT WORTH, TX, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Barricade Therapeutics Corp has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Neil ThaparExecutive Officer

Recently funded in Biotechnology

Other companies that recently filed a Form D

$7.0MRaised

Ovelle Bio Corp.

BiotechnologyDOVER, DE
Jun 2, 2026View SEC Form D
$29.0KRaised

Thiogenesis Therapeutics, Corp.

BiotechnologyTORONTO, A6
Jun 1, 2026View SEC Form D
$55.8MRaised

Contraline, Inc.

BiotechnologyCHARLOTTESVILLE, VA
May 29, 2026View SEC Form D
$22.9KRaised

Conexeu Sciences Inc.

BiotechnologyRENO, NV
May 28, 2026View SEC Form D
$1.2MRaised

SalivIQ Diagnostics Inc.

BiotechnologyHARRISONBURG, VA
May 26, 2026View SEC Form D